Clinical trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute…
NCT00103285 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00103285 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
| Official title | Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL) |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | 3-Dimensional Conformal Radiation Therapy, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Thioguanine and 1 more |
| Enrollment | 5,377 |
| Start date | Apr 11, 2005 |
| Primary completion | Dec 30, 2013 |
| Completion | Mar 31, 2021 |
| First posted | Feb 8, 2005 |
| Last update posted | Jun 14, 2021 |
| Countries | Australia, Canada, New Zealand, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: